← k3vl4r
Log inGet started →

IQV (IQVIA Holdings) Price Forecast

AI-generated price forecast for IQVIA Holdings (IQV) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of August 2026: K3vl4r's AI model currently reads IQV as 4/4 bearish · strong across its horizons (0 of 4 timeframes pointing up), with a last price of 242.53. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

242.53

AI outlook

4/4 bearish · STRONG

Timeframes up

0 / 4

Share𝕏PostTelegram

IQV forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour~3 weeks out▼ Down-16.28%—
4-hour~3 months out▼ Down-30.96%—
Daily~4 months out▼ Down-30.01%—
Weekly~1.9 years out▼ Down-11.57%—

Latest IQV news

From the market-news feed the forecasts are read against.

  • Amgen Stock And The Price Of A Promise · Trefis · Aug 12
  • IQV Stock Gains 42% in 3 Months: Here's What You Should Know · Yahoo · Aug 12
  • Rotation Away From Tech Lifts Moat Index In July · SeekingAlpha · Aug 11
  • How Investors Are Reacting To IQVIA Holdings (IQV) Cardiac Gene Therapy Push And Higher 2026 Revenue Outlook · Yahoo · Aug 9
  • IQVIA, Medera Partner to Accelerate Development of Cardiac Gene Therapies · Yahoo · Aug 6

🔒

See the full IQV forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

IQV forecast — frequently asked

Will IQV go up?

K3vl4r's AI model currently reads IQV as 4/4 bearish · STRONG — 0 of 4 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the IQV price prediction for 2026?

K3vl4r's model projects IQV toward $241.66 over the next ~3 weeks, a -0.2% move from $242.05. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could IQV reach?

Over its longest horizon (~~1.9 years), the model's projected target for IQV is $243.95 (-0.1% vs $244.24). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

CRLMEDPICLRROIVESETGTPPLBOBBOB-USDTHRMIONQCFG-USDETHFI-USDYFI-USDDY

Will IQV reach…?

Will IQV reach $500.00?Will IQV reach $1,000?

Or see the full IQV price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare IQV

IQV vs CRLIQV vs MEDPIQV vs ICLRIQV vs ROIVIQV vs ESEIQV vs TGT

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.